» Articles » PMID: 35203475

CD14 Is Involved in the Interferon Response of Human Macrophages to Rubella Virus Infection

Overview
Journal Biomedicines
Date 2022 Feb 25
PMID 35203475
Authors
Affiliations
Soon will be listed here.
Abstract

Macrophages (MΦ) as specialized immune cells are involved in rubella virus (RuV) pathogenesis and enable the study of its interaction with the innate immune system. A similar replication kinetics of RuV in the two human MΦ types, the pro-inflammatory M1-like (or GM-MΦ) and anti-inflammatory M2-like (M-MΦ), was especially in M-MΦ accompanied by a reduction in the expression of the innate immune receptor CD14. Similar to RuV infection, exogenous interferon (IFN) β induced a loss of glycolytic reserve in M-MΦ, but in contrast to RuV no noticeable influence on CD14 expression was detected. We next tested the contribution of CD14 to the generation of cytokines/chemokines during RuV infection of M-MΦ through the application of anti-CD14 blocking antibodies. Blockage of CD14 prior to RuV infection enhanced generation of virus progeny. In agreement with this observation, the expression of IFNs was significantly reduced in comparison to the isotype control. Additionally, the expression of TNF-α was slightly reduced, whereas the chemokine CXCL10 was not altered. In conclusion, the observed downmodulation of CD14 during RuV infection of M-MΦ appears to contribute to virus-host-adaptation through a reduction of the IFN response.

Citing Articles

Chikungunya virus infection in human microglial C20 cells induces mitochondria-mediated apoptosis.

Kumar N, Santhoshkumar R, Venkataswamy M Front Cell Infect Microbiol. 2024; 14:1380736.

PMID: 38716191 PMC: 11074397. DOI: 10.3389/fcimb.2024.1380736.


Macrophages in Health and Non-Infectious Disease 2.0.

Bezsonov E, Gratchev A, Orekhov A Biomedicines. 2022; 10(6).

PMID: 35740237 PMC: 9219829. DOI: 10.3390/biomedicines10061215.


Interferon Signaling-Dependent Contribution of Glycolysis to Rubella Virus Infection.

Schilling E, Wald M, Schulz J, Werner L, Claus C Pathogens. 2022; 11(5).

PMID: 35631058 PMC: 9146913. DOI: 10.3390/pathogens11050537.

References
1.
Rouse B, Horohov D . Immunosuppression in viral infections. Rev Infect Dis. 1986; 8(6):850-73. PMC: 7792945. DOI: 10.1093/clinids/8.6.850. View

2.
Perelygina L, Plotkin S, Russo P, Hautala T, Bonilla F, Ochs H . Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies. J Allergy Clin Immunol. 2016; 138(5):1436-1439.e11. PMC: 5392721. DOI: 10.1016/j.jaci.2016.06.030. View

3.
Wu Z, Zhang Z, Lei Z, Lei P . CD14: Biology and role in the pathogenesis of disease. Cytokine Growth Factor Rev. 2019; 48:24-31. DOI: 10.1016/j.cytogfr.2019.06.003. View

4.
Jimenez-Duran G, Luque-Martin R, Patel M, Koppe E, Bernard S, Sharp C . Pharmacological validation of targets regulating CD14 during macrophage differentiation. EBioMedicine. 2020; 61:103039. PMC: 7648121. DOI: 10.1016/j.ebiom.2020.103039. View

5.
Ovsyannikova I, Salk H, Larrabee B, Pankratz V, Poland G . Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children. Immunogenetics. 2015; 67(10):547-61. PMC: 4587390. DOI: 10.1007/s00251-015-0864-z. View